Navigation Links
CoDa Therapeutics' NEXAGON® Wound Healing Gel Named to Windhover's 'Top 10 HOT SPACE Projects to Watch'
Date:9/17/2010

ronic wounds, scarring, abnormal scarring, inflammation and pain, fibrosis, surgical adhesions, and orthopedic procedures, as well as combination therapies and improved medical devices. For further information, please visit www.codatherapeutics.com.

About NEXAGON® The active ingredient in NEXAGON®, which has been shown to work across a wide variety of tissues, is CODA001, a natural, unmodified antisense oligonucleotide that down-regulates the key gap junction protein connexin43 to dampen inflammatory responses and enhance healing.  Data shows that for optimal healing connexin43 is normally dialed-down at the edges of acute wounds (i.e., wounds that will heal normally).  Conversely, other company data demonstrate that connexin43 is wrongly up-regulated at the edge of chronic wounds (i.e., wounds that are slow or difficult to heal such as venous and diabetic ulcers).  CoDa believes that one can better target available medical options and design more effective wound-healing alternatives by devising a therapeutic approach based on biological mechanisms naturally at work or conversely, at fault, in a given situation. The answer is thought to lie in connexin43, which can be seen as a "master switch" in wound healing that is temporarily turned "off" for superior healing of acute wounds, and when left "on" can lead to the unwanted inflammation and/or stalled healing characteristic of chronic wounds.

About Scisive Consulting, LPScisive Consulting, LP, is provides management consulting services for healthcare businesses. It offers strategy development services for innovation sourcing, new market entry, portfolio rationalization, life-cycle management, product line and therapeutic area diversification, clinical development and commercialization, pricing, marketing channels and product launches, and transformational acquisitions projects. The company al
'/>"/>

SOURCE CoDa Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
2. Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
3. Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy
4. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
5. Halozyme Therapeutics Announces Public Offering of Common Stock
6. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
7. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
8. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
9. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
10. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
(Date:9/4/2015)... , Sep. 04, 2015 ... the addition of the "Stability Testing of Pharmaceuticals ... their offering. By attending this comprehensive two ... to design efficient stability studies that are suitable for ... appropriate stability studies and manage stability samples and facilities ...
(Date:9/3/2015)... , Sept. 3, 2015 ... Potentials of New Drugs, Industry Changes and Emerging ... the human ovaries? Visiongain,s new study forecasts those ... growth in that industry. You also explore trends, ... Our report gives revenue predictions to 2025 ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6
... LOS ANGELES , July 13 Medical Tactile, Inc. ... Medical Technologies, Inc., based in Victoria , Canada , has ... the exclusive Sales & Marketing rights for SureTouch™ , the non-invasive ... , , , ...
... New England Biolabs (NEB) has expanded its line ... Quick DNA Sample Prep Reagent Set 2 and Master Mix ... GS FLX Titanium™ and GS Junior™ instruments. These new products ... library preparation. The Master Mix Set further streamlines the workflow, ...
Cached Medicine Technology:Partnership Brings Breast Image Documentation Technology to Women Around the World 2New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms 2
(Date:9/4/2015)... Forge, PA (PRWEB) , ... September 04, 2015 , ... ... growth in and around the home is quite common. Mold can grow anywhere - ... areas around leaking pipes. Checking for excessive moisture and water in the home is ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety ... visits which affects hospitals’ abilities to provide quality service to those with serious needs, ... this problem has recently presented itself, the new telemedicine platform and app, DocChat ...
(Date:9/4/2015)... DC (PRWEB) , ... September 04, 2015 , ... ... they all pale in comparison to settlements under the Stark physician self-referral law. ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail ...
(Date:9/4/2015)... ... 04, 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg ... Hope event supporting families affected by autism, raising nearly $250,000. , 150 guests, ... at the Oscar Swan Inn to support the cause. , McCarthy tugged the ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... , SUNDAY, June 5 (HealthDay News) -- Four of the ... serious birth defects when taken early in pregnancy, a new study ... risk, the international team of researchers reported in the June 6 ... show that dose selection is as crucial as the choice of ...
... By Amanda Gardner HealthDay Reporter , SUNDAY, June ... cancer only take four courses of two chemotherapy drugs and ... those drugs may delay return of the deadly disease, new ... Spanish scientists report that staying on Alimta (pemextrexed) delayed recurrence ...
... Amanda Gardner HealthDay Reporter , SATURDAY, June ... to cut the odds of breast cancer by 65 ... And unlike other anti-estrogen therapies such as tamoxifen ... risk of endocrine cancer or blood clots, although it ...
... YORK (June 5, 2011) Less invasive catheter-based aortic valve ... for patients at high risk for surgery. Results from ... world,s first randomized clinical trial of a transcatheter aortic heart ... Journal of Medicine . The findings were also presented on ...
... Reporter , SATURDAY, June 4 (HealthDay News) -- For ... suggests that the sooner chemotherapy starts following the operation, ... the first four weeks post-surgery that chemotherapy is delayed, ... "What our research has indicated is that giving ...
... individuals with Lynch syndrome, a hereditary cancer syndrome that carries ... of other cancers, researchers have identified mutations associated with a ... for ovarian and endometrial cancer, according to a study in ... issue on cancer. The study is being published early online ...
Cached Medicine News:Health News:Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent 2Health News:Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent 3Health News:Taking Chemo Drug Continuously Delayed Lung Cancer's Return 2Health News:Taking Chemo Drug Continuously Delayed Lung Cancer's Return 3Health News:Aromasin Reduced Breast Cancer Risk in Postmenopausal Women 2Health News:Aromasin Reduced Breast Cancer Risk in Postmenopausal Women 3Health News:PARTNER shows similar 1-year survival for catheter-based AVR and open AVR in high-risk patients 2Health News:PARTNER shows similar 1-year survival for catheter-based AVR and open AVR in high-risk patients 3Health News:After Colon Cancer Surgery, Early Chemo May Pay Off 2Health News:After Colon Cancer Surgery, Early Chemo May Pay Off 3Health News:Study identifies genetic mutations associated with cancer risk for hereditary cancer syndrome 2Health News:Study identifies genetic mutations associated with cancer risk for hereditary cancer syndrome 3
Posterior Lumbar Retractor System ideally suited for spinal fixation, laminectomy, PLIF procedures. This system brings microdiscectomy to multi-level reconstruction....
Puros allografts is a family of bone products specially designed and processed to meet the demanding needs of spine surgeons. The grafts are processed using the proprietary Tutoplast process....
8 mm S Graftech cervical spacer....
... Most popular plating system ... Lorenz 1.5 mm titanium system ... screw and plating options for ... plates and screws are used ...
Medicine Products: